Altered BDNF and Dopamine Levels In Depression

Doctor Abraham Zangen point out that dopamine and BDNF levels in the nucleus accumbens and hippocampus of depressed patients are different. Treatment with antidepressants or ECT can impact these differences.

Yes. So I did not mention that but dopamine is also altered in the nucleus accumbens by brain stimulation and BDNF (brain-derived neurotrophic factor) is altered by repeated stimulation. However, in depressive patients, there are some observations of increased BDNF (brain-derived neurotrophic factor) levels in the nucleus accumbens unlike what we see in the hippocampus. [This is] in opposite direction of alteration in depressive patients, and antidepressant drugs or electroconvulsive therapy was shown to decrease BDNF levels in the accumbens, unlike what it does in the hippocampus. I think there is less data on that. There is a group in Texas actually studying and they are more focusing on the question of what happens to BDNF in the nucleus accumbens, and they show this type of inverse relationship between BDNF in the accumbens and the hippocampus. My lab is focusing right now especially on the changes in the hippocampus.

depression, bdnf, dopamine, nucleus, accumbens, hippocampus, depressive, antidepressant, brain derived neurotrophic factor, abraham, zangen

Related Content

2328. Changing BDNF Levels with Depression Treatment

Doctor Abraham Zangen describes how transcranial magnetic stimulation (TMS) may affect levels of BDNF in the hippocampus, thereby treating depression.

  • ID: 2328
  • Source: G2C

1465. BDNF Gene

Brain-derived neurotrophic factor (BDNF) is mainly expressed in the central nervous system. It has attracted much attention as a depression candidate gene.

  • ID: 1465
  • Source: G2C

2329. The Brain Rewad System - Brain Structures

Doctor Abraham Zangen discusses the key structures underlying the brain reward system, a complex neural network that includes the nucleus accumbens and hippocampus.

  • ID: 2329
  • Source: G2C

847. Treating Depression

Individual variations in antidepressant treatment outcomes.

  • ID: 847
  • Source: G2C

2326. TMS Treatment for Depression

Doctor Abraham Zangen discusses how transcranial magnetic stimulation (TMS) can stimulate different areas of the brain and treat depression.

  • ID: 2326
  • Source: G2C

1392. Biochemistry of Depression

Doctor Jon Lieberman discusses three neurotransmitters that have been associated with depression - dopamine, serotonin, and norepinephrine.

  • ID: 1392
  • Source: G2C

2332. TMS versus DBS Treatments for Depression

Doctor Abraham Zangen discusses two techniques for treating depression, which involve electrically stimulating the brain - transcranial magnietic stimulation (TMS) and deep brain stimulation (DBS).

  • ID: 2332
  • Source: G2C

2321. Depression Affects 1 in 10 People

Doctor Abraham Zangen explains that clinical depression is extremely common, affecting one in ten people at some stage in their life.

  • ID: 2321
  • Source: G2C

2322. Electroconvulsive Therapy - Effectiveness

Doctor Abraham Zangen explains that electroconvulsive therapy can be an effective treatment for patients who do not respond to antidepressant medication.

  • ID: 2322
  • Source: G2C

2212. BDNF - brain-derived neurotrophic factor

Professor Bruce McEwen introduces BDNF, a class of neurotrophic molecules released by excitatory neurotransmission and associated with key process and disorders.

  • ID: 2212
  • Source: G2C